Cosmos Health Inc. - Common Stock (COSM)
Industrials › Wholesale-Drugs, Proprietaries & Druggists' Sundries
Price History
Feb 9, 2026 — Aug 21, 2026Investment Snapshot
- P/B of 1.15 — trading near book value
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -82.6%
- Revenue growing at 20% annually
Cosmos Health Inc. - Common Stock (COSM) is a Industrials company operating in Wholesale-Drugs, Proprietaries & Druggists' Sundries, listed on the NASDAQ , with a market capitalisation of $24 million . Key value metrics: P/B ratio 1.15, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cosmos Health Inc. - Common Stock — Fundamental Analysis Summary
On financial health, COSM shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -82.6% (sector average: 6.1%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for COSM is 65/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
COSM reports a thin gross margin of 9.7% (sector average: 14.5%) and a negative operating margin of -13.9%.
COSM shows revenue growing at 20% year-over-year, with earnings declining at 18%.